Azpiroz María F, Laviña Magela
Sección Fisiología y Genética Bacterianas, Facultad de Ciencias, Iguá 4225, Montevideo 11.400, Uruguay.
Antimicrob Agents Chemother. 2007 Jul;51(7):2412-9. doi: 10.1128/AAC.01606-06. Epub 2007 Apr 23.
Microcins are gene-encoded peptide antibiotics produced by enterobacteria that act on strains of gram-negative bacteria. In this work, we concentrated on higher-molecular-mass microcins, i.e., those possessing 60 or more amino acids. They can be subdivided into unmodified and posttranslationally modified peptides. In both cases, they exhibit conserved C-terminal sequences that appear to be characteristic of each subgroup. In the hypothesis that these sequences could correspond to domains, gene fusions between the activity genes for the unmodified microcin colicin V and the modified microcin H47 were constructed. These two microcins differ in their mode of synthesis, uptake, target, and specific immunity. Through this experimental approach, chimeric peptides with exchanged C-terminal sequences were encoded. Cells carrying the fusions in different genetic contexts were then assayed for antibiotic production. Many of them produced antibiotic activities with recombinant properties: the toxicity of one microcin and the mode of uptake of the other. The results led to the identification of a modular structure of colicin V and microcin H47, with the recognition of two domains in their peptide chains: a toxic N-terminal domain and an uptake C-terminal domain. This modular design would be shared by other microcins from each subgroup.
微菌素是由肠杆菌产生的基因编码肽类抗生素,作用于革兰氏阴性菌菌株。在这项工作中,我们专注于高分子量微菌素,即那些含有60个或更多氨基酸的微菌素。它们可细分为未修饰肽和翻译后修饰肽。在这两种情况下,它们都表现出保守的C端序列,这似乎是每个亚组的特征。基于这些序列可能对应于结构域的假设,构建了未修饰的微菌素大肠杆菌素V和修饰的微菌素H47的活性基因之间的基因融合体。这两种微菌素在合成方式、摄取方式、作用靶点和特异性免疫方面存在差异。通过这种实验方法,编码了具有交换C端序列的嵌合肽。然后对在不同遗传背景下携带融合体的细胞进行抗生素生产检测。其中许多细胞产生了具有重组特性的抗生素活性:一种微菌素的毒性和另一种微菌素的摄取方式。结果确定了大肠杆菌素V和微菌素H47的模块化结构,在其肽链中识别出两个结构域:有毒的N端结构域和摄取相关的C端结构域。这种模块化设计将为每个亚组的其他微菌素所共有。